Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1996-12-24
|
pubmed:abstractText |
Biochemical control using serial posttreatment serum prostate specific antigen (PSA) levels is being increasingly used to assess treatment efficacy for localized prostate cancer. However, no standardized definition of biochemical control has been established. We reviewed our experience treating patients with localized prostate cancer and applied three different commonly used definitions of biochemical control to determine if differences in therapeutic outcome would be observed.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0360-3016
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
565-71
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8948340-Aged,
pubmed-meshheading:8948340-Aged, 80 and over,
pubmed-meshheading:8948340-Humans,
pubmed-meshheading:8948340-Male,
pubmed-meshheading:8948340-Middle Aged,
pubmed-meshheading:8948340-Prostate-Specific Antigen,
pubmed-meshheading:8948340-Prostatic Neoplasms,
pubmed-meshheading:8948340-Reference Values
|
pubmed:year |
1996
|
pubmed:articleTitle |
Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control.
|
pubmed:affiliation |
Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI 48073, USA.
|
pubmed:publicationType |
Journal Article
|